Anatomic Pathology Market by Services (Cytopathology, Histopathology), Prōduct (Consumables, Instruments), Application, End User - Global Forecast 2024-2030
The Anatomic Pathology Market size was estimated at USD 34.38 billion in 2023 and expected to reach USD 36.95 billion in 2024, at a CAGR 7.56% to reach USD 57.27 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Anatomic Pathology Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Anatomic Pathology Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Anatomic Pathology Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc, Amos Scientific Pty Ltd, Bio SB, BioGenex Laboratories, Cardinal Health, Inc., Diapath S.p.A., Enzo Biochem, Inc., F. Hoffmann-La Roche Ltd., Histo-Line Laboratories, Milestone Medical, NeoGenomics Laboratories, Inc., PHC Holdings Corporation, RareCyte, Inc., Sakura Finetek USA, Inc., and VolitionRx Limited.
Market Segmentation & Coverage
This research report categorizes the Anatomic Pathology Market to forecast the revenues and analyze trends in each of the following sub-markets:
Services
Cytopathology
Consumables
Antibodies
Cell Processors
Disease Diagnostics
Clinical Laboratories
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Anatomic Pathology Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Anatomic Pathology Market?
- What are the technology trends and regulatory frameworks in the Anatomic Pathology Market?
- What is the market share of the leading vendors in the Anatomic Pathology Market?
- Which modes and strategic moves are suitable for entering the Anatomic Pathology Market?
Note: PDF & Excel + Online Access - 1 Year
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Anatomic Pathology Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising reliance on biomarkers-based pathology tests and procedures
- 5.1.1.2. Increasing prevalence of cancer and other chronic diseases
- 5.1.1.3. Accelerating focus towards personalized medicines
- 5.1.2. Restraints
- 5.1.2.1. Limited availability of defined standards and high cost
- 5.1.3. Opportunities
- 5.1.3.1. Growing use of advanced pathology equipment such as gross imaging, staining systems, and digital microscopes
- 5.1.3.2. Strategic partnership and agreement among companies for the introduction of an effective portfolio
- 5.1.4. Challenges
- 5.1.4.1. Dearth of skilled professionals
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Anatomic Pathology Market, by Services
- 6.1. Introduction
- 6.2. Cytopathology
- 6.3. Histopathology
- 7. Anatomic Pathology Market, by Prōduct
- 7.1. Introduction
- 7.2. Consumables
- 7.3.1. Antibodies
- 7.3.2. Kits & Reagents
- 7.3.3. Probes
- 7.3. Instruments
- 7.4.1. Cell Processors
- 7.4.2. Coverslippers
- 7.4.3. Embedding Systems
- 7.4.4. Microtomes
- 7.4.5. Slide Staining Systems
- 7.4.6. Tissue Processing Systems
- 8. Anatomic Pathology Market, by Application
- 8.1. Introduction
- 8.2. Disease Diagnostics
- 8.3. Medical Research
- 9. Anatomic Pathology Market, by End User
- 9.1. Introduction
- 9.2. Clinical Laboratories
- 9.3. Hospital Laboratories
- 10. Americas Anatomic Pathology Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Anatomic Pathology Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Anatomic Pathology Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. Agilent Technologies, Inc
- 14.1.2. Amos Scientific Pty Ltd
- 14.1.3. Bio SB
- 14.1.4. BioGenex Laboratories
- 14.1.5. Cardinal Health, Inc.
- 14.1.6. Diapath S.p.A.
- 14.1.7. Enzo Biochem, Inc.
- 14.1.8. F. Hoffmann-La Roche Ltd.
- 14.1.9. Histo-Line Laboratories
- 14.1.10. Milestone Medical
- 14.1.11. NeoGenomics Laboratories, Inc.
- 14.1.12. PHC Holdings Corporation
- 14.1.13. RareCyte, Inc.
- 14.1.14. Sakura Finetek USA, Inc.
- 14.1.15. VolitionRx Limited
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. ANATOMIC PATHOLOGY MARKET RESEARCH PROCESS
- FIGURE 2. ANATOMIC PATHOLOGY MARKET SIZE, 2023 VS 2030
- FIGURE 3. ANATOMIC PATHOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. ANATOMIC PATHOLOGY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. ANATOMIC PATHOLOGY MARKET DYNAMICS
- FIGURE 7. ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2030 (%)
- FIGURE 8. ANATOMIC PATHOLOGY MARKET SIZE, BY SERVICES, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. ANATOMIC PATHOLOGY MARKET SIZE, BY PRŌDUCT, 2023 VS 2030 (%)
- FIGURE 10. ANATOMIC PATHOLOGY MARKET SIZE, BY PRŌDUCT, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. ANATOMIC PATHOLOGY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2023 VS 2030 (%)
- FIGURE 14. ANATOMIC PATHOLOGY MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES ANATOMIC PATHOLOGY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA ANATOMIC PATHOLOGY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. ANATOMIC PATHOLOGY MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. ANATOMIC PATHOLOGY MARKET SHARE, BY KEY PLAYER, 2023
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook